Related references
Note: Only part of the references are listed.Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis
Adria Juanola et al.
JOURNAL OF HEPATOLOGY (2022)
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Elsa Sola et al.
JOURNAL OF HEPATOLOGY (2021)
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites
Paolo Caraceni et al.
JOURNAL OF HEPATOLOGY (2021)
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
Maurizio Baldassarre et al.
HEPATOLOGY (2021)
Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
F. Wong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis
Louise China et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016
Christopher Ma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
The Alter Ego of Albumin in Cirrhosis
Gautam Mehta et al.
HEPATOLOGY (2021)
The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality
Patrick Starlinger et al.
HEPATOLOGY (2021)
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Scott W. Biggins et al.
HEPATOLOGY (2021)
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis
Candid Villanueva et al.
JOURNAL OF HEPATOLOGY (2021)
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)
Raffaele Bruno et al.
DIGESTIVE AND LIVER DISEASE (2021)
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2021)
Liver cirrhosis
Pere Gines et al.
LANCET (2021)
Albumin in decompensated cirrhosis: new concepts and perspectives
Mauro Bernardi et al.
GUT (2020)
Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis
Mireia Casulleras et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Hepatorenal syndrome: pathophysiology, diagnosis, and management
Douglas A. Simonetto et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Long-term administration of human albumin improves survival in patients with cirrhosis and refractory ascites
Marco Di Pascoli et al.
LIVER INTERNATIONAL (2019)
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis
Javier Fernandez et al.
GASTROENTEROLOGY (2019)
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
Javier Fernández et al.
Clinical Gastroenterology and Hepatology (2019)
Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease
Louise China et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial
Louise China et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Cell death markers in patients with cirrhosis and acute decompensation
Stewart Macdonald et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
JOURNAL OF HEPATOLOGY (2018)
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Paolo Caraceni et al.
LANCET (2018)
Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis
Jose Alcaraz-Quiles et al.
HEPATOLOGY (2018)
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial
Elsa Sola et al.
JOURNAL OF HEPATOLOGY (2018)
Hepatorenal syndrome
Pere Gines et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Hyperoxidized Albumin Modulates Neutrophils to Induce Oxidative Stress and Inflammation in Severe Alcoholic Hepatitis
Sukanta Das et al.
HEPATOLOGY (2017)
Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis
Marina Naldi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Systemic Inflammation in Decompensated Cirrhosis: Characterization and Role in Acute-on-Chronic Liver Failure
Joan Claria et al.
HEPATOLOGY (2016)
Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis
Elsa Sola et al.
JOURNAL OF HEPATOLOGY (2016)
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
Marta Cavallin et al.
HEPATOLOGY (2015)
Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial
Thierry Thevenot et al.
JOURNAL OF HEPATOLOGY (2015)
Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites
Paolo Angeli et al.
JOURNAL OF HEPATOLOGY (2015)
Posttranscriptional Changes of Serum Albumin: Clinical and Prognostic Significance in Hospitalized Patients With Cirrhosis
Marco Domenicali et al.
HEPATOLOGY (2014)
Human serum albumin, systemic inflammation, and cirrhosis
Vicente Arroyo et al.
JOURNAL OF HEPATOLOGY (2014)
Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms
Alessia Bortoluzzi et al.
HEPATOLOGY (2013)
Albumin: Pathophysiologic Basis of Its Role in the Treatment of Cirrhosis and Its Complications
Rita Garcia-Martinez et al.
HEPATOLOGY (2013)
Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema
Elsa Sola et al.
JOURNAL OF HEPATOLOGY (2012)
Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study
Monica Guevara et al.
JOURNAL OF HEPATOLOGY (2012)
Human serum albumin: From bench to bedside
Gabriella Fanali et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Human Serum Albumin in the Clinical Syndrome of Heart Failure
Stephane Arques et al.
JOURNAL OF CARDIAC FAILURE (2011)
Alterations in the Functional Capacity of Albumin in Patients with Decompensated Cirrhosis Is Associated with Increased Mortality
Rajiv Jalan et al.
HEPATOLOGY (2009)
MEDICAL PROGRESS Renal Failure in Cirrhosis
Pere Gines et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: An unblinded randomized trial
Roberto Giulio Romanelli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis
J Fernández et al.
HEPATOLOGY (2005)
Share Paper
